Delphia (USA)’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,133	Closed	-$65K	–	377
2022 Q2	$65K	Buy	+1,133	New	+$65K	0.04%	367
2022 Q1	–	Sell	-1,258	Closed	-$255K	–	370
2021 Q4	$255K	Buy	+1,258	New	+$255K	0.27%	150